ArticleMedical oncology (Northwood, London, England)2012

Characterization of ABL exon 7 deletion by molecular genetic and bioinformatic methods reveals no association with imatinib resistance in chronic myeloid leukemia.

Nóra Meggyesi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.